Washing the wound immediately with soap and water is the single most important first step after any exposure to a bloodborne pathogen, whether through a needlestick, a splash to mucous membranes, or contact with broken skin. What happens in the minutes and hours after that initial wash determines how much risk you actually face and how effectively that risk can be reduced. The post-exposure response involves a specific sequence: wound care, risk assessment, possible prophylactic medications, and a schedule of follow-up blood tests that can stretch over several months.
Clean the Wound Right Away
If you have been stuck by a needle or cut by a contaminated sharp object, wash the wound thoroughly with soap and running water. Do not scrub aggressively or use bleach, hydrogen peroxide, or other harsh agents directly on the wound. If blood or body fluid has splashed into your eyes, flush them with clean water or saline. If it has reached your mouth, rinse repeatedly and spit out any material.
One common instinct is to squeeze the wound to force blood out. This is not recommended and can actually drive contaminated material deeper into tissue. A study of operating room nurses found that about 18% squeezed the wound after an exposure, while roughly 10% did not clean the area immediately at all. Both responses work against you.
1PubMed. Practices and impacts post-exposure to blood and body fluid in operating room nurses: A cross-sectional studySurveys from other settings have found similar patterns, with some healthcare workers using methylated spirit or bleach-based solutions on puncture wounds, and a small percentage doing nothing at all.2PubMed Central. Prevalence and factors associated with percutaneous injuries and splash exposures among health-care workers in a provincial hospital, Kenya, 2010 The goal is simple: gentle but thorough washing with soap and water, then get to a medical professional as fast as possible. Everything after that depends on what the source of the blood was carrying.
Which Pathogens Matter Most
Dozens of infections can theoretically be transmitted through blood, but three viruses account for the vast majority of concern after an occupational exposure: HIV, hepatitis B (HBV), and hepatitis C (HCV).3PubMed Central. Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health care settings: a review of risk factors and guidelines for prevention The risk of actually catching an infection from a single needlestick varies enormously depending on which virus is involved.
HBV is by far the most transmissible. An unvaccinated person stuck with a needle contaminated by hepatitis B-positive blood faces a transmission risk that has been estimated at thousands of times higher than for HIV from the same type of exposure.4American Journal of Infectious Control. The risks of occupational exposure and infection by human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in the dialysis setting HCV sits somewhere in between, and HIV carries the lowest per-exposure risk of the three. This does not mean HIV exposure can be shrugged off, but it does explain why the post-exposure response differs for each pathogen.
The type of exposure also shapes your risk. A deep puncture wound from a hollow-bore needle that was visibly contaminated with blood is far more dangerous than a superficial scratch or a small splash to intact skin. Whether the source patient has a high viral load matters too. A risk assessment that weighs all these factors is typically performed by an occupational health provider or emergency department physician shortly after the incident, and it drives every decision that follows.5Journal of Patient Safety and Risk Management. Management of bloodborne pathogen exposures in primary care: A quality improvement project
HIV Post-Exposure Prophylaxis
Post-exposure prophylaxis for HIV, commonly called PEP, is a course of antiretroviral medications taken for 28 days to prevent the virus from establishing infection. It is estimated to reduce the risk of HIV transmission by at least 80%.6PubMed. Post-exposure prophylaxis for HIV infection The catch is timing. PEP works best when the first dose is taken as soon as possible after exposure, ideally within a few hours. The absolute upper limit for starting PEP is 72 hours, and every hour of delay reduces its effectiveness.
Despite how critical the timing window is, awareness of it is surprisingly poor. One study found that only about a quarter of people at high risk for HIV exposure knew when PEP needed to be started to be effective, meaning most people who could benefit from it miss the window entirely.7PubMed. Limited awareness of the effective timing of HIV post-exposure prophylaxis among people with high-risk exposure to HIV If you think you have been exposed to HIV through any route, the message is straightforward: get to a healthcare provider or emergency department immediately and ask about PEP. The first dose should not be delayed while waiting for lab results.
PEP is not a casual medication. The 28-day regimen typically involves a combination of two or three antiretroviral drugs, and side effects like nausea, fatigue, and headache are common enough that some people stop taking it early. Completing the full course matters. Deciding whether to initiate PEP involves balancing the toxicity of the drugs against the actual risk of the exposure, which is why the risk assessment performed by a clinician is so important. If the source patient is known to be HIV-negative, PEP is generally not indicated, sparing you a month of medication you do not need.
What Happens with Hepatitis B
Your hepatitis B vaccination status is the single biggest factor in how a potential HBV exposure plays out. If you were vaccinated and developed a strong antibody response, your risk after a needlestick is essentially negligible. Healthcare workers are supposed to be immunized against HBV, and ideally should have documentation of their antibody response to vaccination, because knowing that status ahead of time streamlines the entire post-exposure response.8PubMed Central. Management of occupational exposure to blood and body fluids in primary care
If you are unvaccinated or did not respond to the vaccine, the situation is more urgent. Hepatitis B immune globulin (HBIG) provides immediate passive protection by delivering pre-formed antibodies against the virus. It is typically given alongside the first dose of the hepatitis B vaccine, combining short-term and long-term protection.9PubMed. Review: hepatitis B immune globulin for prevention of hepatitis B infection HBIG needs to be administered promptly after exposure, ideally within 24 hours. This two-pronged approach is highly effective at preventing infection in people who were previously unprotected.
If you are a healthcare worker and you do not know your HBV vaccination status or antibody level, this is something worth sorting out before you ever face an exposure. Having that information on file turns what could be a scramble for urgent treatment into a reassurance that you are already protected.
Hepatitis C Has No Prophylaxis
Unlike HIV and HBV, there is currently no vaccine for hepatitis C and no approved post-exposure prophylaxis. The approach after a potential HCV exposure is entirely about surveillance: testing early and often so that if infection does occur, it is caught and treated before it becomes chronic.
CDC guidance lays out a specific testing schedule. Baseline blood tests for hepatitis C antibodies should be drawn as soon as possible after the exposure, ideally within 48 hours. If the source patient is confirmed to have active HCV infection, or if their status is unknown, follow-up testing for HCV RNA should happen at three to six weeks post-exposure. If that test is negative, a final antibody test is recommended at four to six months.10Morbidity and Mortality Weekly Report. Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus — CDC Guidance, United States, 2020 If HCV RNA is detected at any point, you would be referred immediately for treatment. Modern direct-acting antiviral regimens cure hepatitis C in the vast majority of cases, so early detection translates directly into better outcomes.
The absence of a preventive option for HCV is a real gap. It means the exposed person faces weeks of uncertainty while waiting for follow-up test results. This is where the psychological toll of an exposure event tends to be heaviest, a topic that gets far less attention than it deserves.
The Testing Timeline
After any significant bloodborne pathogen exposure, both you and the source patient need blood drawn. The source patient’s blood is tested for HIV, HBV, and HCV to determine what, if anything, you were actually exposed to. Your baseline blood draw establishes your infection status at the time of exposure, which is essential for proving that any later positive result is actually related to the incident rather than a pre-existing condition.
Follow-up testing for an exposed person typically unfolds over months. The exact schedule depends on which pathogens are of concern and which prophylactic treatments were given. For HIV, follow-up testing is usually done at six weeks, 12 weeks, and sometimes six months post-exposure. For HCV, the schedule described above applies. For HBV, the timeline depends on vaccination status and whether HBIG was administered.
It is worth knowing that the source patient may not always cooperate. In some cases, the person whose blood was involved refuses testing, or the source is unknown altogether (a discarded needle found in a public space, for example). When the source cannot be tested, clinicians generally err on the side of treating the exposure as higher risk. PEP for HIV is more likely to be offered, and the follow-up testing schedule is more comprehensive.
Non-Occupational Exposures
Bloodborne pathogen exposure is not limited to healthcare settings. Sexual assault, sharing injection equipment, and accidental contact with someone else’s blood can all pose a risk. The same general framework applies: wash the area, seek medical care immediately, and get a risk assessment. The medications are identical whether the exposure happened in an operating room or outside one.
For non-occupational HIV exposures, updated CDC recommendations emphasize that the first dose of PEP should be provided as soon as possible, ideally within 24 hours, and no later than 72 hours. The initial dose should not be delayed for lab results, and the full course lasts 28 days.11Morbidity and Mortality Weekly Report. Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV — CDC Recommendations, United States, 2025
After sexual assault, the post-exposure protocol expands beyond bloodborne pathogens to include emergency contraception, screening for sexually transmitted infections, and psychosocial support.12PubMed Central. Post-exposure prophylaxis for sexual assault victim-survivors: Guidelines and best practices Research on PEP acceptance after sexual assault has found that certain exposure characteristics influence whether patients agree to start treatment. Assault involving multiple perpetrators, the absence of a condom, or visible genital injury all made patients more likely to accept PEP.13PubMed Central. Nonoccupational Postexposure Human Immunodeficiency Virus Prophylaxis: Acceptance Following Sexual Assault These findings are a reminder that even when PEP is offered, barriers to uptake remain, and the emotional state of the person at the time of the medical visit plays a significant role.
Pregnancy and Other Special Circumstances
Pregnant individuals who are exposed to a bloodborne pathogen face the same urgency around PEP but need careful drug selection. Standard antiretroviral combinations used for PEP may not all be safe during pregnancy, so the regimen has to be tailored to avoid harm to the fetus while still protecting the mother.14PubMed. Post-exposure prophylaxis for Blood-Borne Viral (BBV) Infections If you are pregnant and face a potential HIV exposure, make sure the prescribing clinician knows, because the default PEP regimen may need adjustment.
Immunocompromised individuals present a different challenge. A person on chemotherapy, taking immunosuppressive drugs after an organ transplant, or living with an immune-suppressing condition may have a blunted antibody response to HBV vaccination, meaning their prior immunization offers less protection. These individuals may need HBIG even if they were technically vaccinated. The post-exposure risk assessment should always account for the exposed person’s immune status, not just the source patient’s infection profile.
The Psychological Toll Is Real
The weeks and months between exposure and final test results are frequently described by healthcare workers as among the most stressful experiences of their careers. This is not just anecdotal. A study of hospital workers in Laos found that those who had experienced a needlestick in the prior six months had significantly higher anxiety scores than those who had not, and over 40% reported being more afraid of needles and sharps in the two weeks immediately after the injury.15PubMed Central. Anxiety and perceived psychological impact associated with needle stick and sharp device injury among tertiary hospital workers, Vientiane, Lao PDR
Another study found that over 40% of healthcare workers who had experienced a needlestick reported severe anxiety afterward, and more than half reported high perceived stress levels. Workers who were unvaccinated against hepatitis B were particularly affected, likely because they faced a greater degree of genuine uncertainty about their risk.16PubMed. Mental health support need among health care workers post needle stick injuries: A sequential mixed method study Despite this, formal mental health support after needlestick injuries is rarely standard practice. Most post-exposure protocols focus entirely on the medical steps and the paperwork, leaving the emotional fallout for the individual to manage alone.
If you are going through the post-exposure process and finding the anxiety difficult to manage, it is worth asking your occupational health department or primary care provider about counseling resources. The stress is predictable, normal, and treatable. You do not need to white-knuckle your way through the waiting period.
When the Source Patient Refuses Testing
A recurring practical and ethical dilemma arises when the source patient declines to have their blood tested. Without knowing the source’s HIV, HBV, and HCV status, the exposed worker and their clinician are left making treatment decisions in the dark. PEP involves taking medications that have real side effects and toxicity, so starting a 28-day course when the source patient may be entirely uninfected means accepting drug risks with no compensating benefit. But forgoing PEP when the source actually is infected means missing the narrow window to prevent transmission.17PubMed Central. Unconsented HIV testing in cases of occupational exposure: ethics, law, and policy
Laws on whether a source patient can be tested without consent vary by jurisdiction. Some places allow compulsory testing of the source patient after an occupational exposure under specific circumstances. Others protect the source patient’s right to refuse. In practice, when the source’s status is unknown, clinicians tend to recommend starting PEP immediately and reassessing if and when more information becomes available. This “start now, stop if unneeded” approach avoids the worst-case scenario of missing the treatment window, even though it means some people will take medications they ultimately did not need.
Preventing Exposures in the First Place
While the focus of this article is what to do after an exposure, it is worth noting how much engineering controls have changed the landscape. Safety-engineered devices, such as retractable needles, self-sheathing IV catheters, and blunt suture needles, have substantially reduced needlestick injury rates among healthcare workers. A multi-centre study in Japan found that safety-engineered devices reduced needlestick injury rates significantly across all device categories tested, including winged steel needles, IV catheter stylets, and suture needles.18PubMed. Reducing needlestick injuries through safety-engineered devices: results of a Japanese multi-centre study
A broader review of published studies found that implementation of safety-engineered devices was associated with reductions in percutaneous injury rates ranging from 22% to 100%, though many of the studies had design limitations and the devices were often introduced alongside other safety interventions like training programs.19Clinical Infectious Diseases. Efficacy of Safety-Engineered Device Implementation in the Prevention of Percutaneous Injuries: A Review of Published Studies A 20-year retrospective study at a tertiary hospital found a statistically significant decline in injury rates among nurses after these devices were introduced.20PubMed Central. Did safety-engineered device implementation contribute to reducing the risk of needlestick and sharps injuries? Retrospective investigation of 20 years of observation in a specialist tertiary referral hospital
For individuals outside healthcare, the most relevant prevention measures are simpler: do not share injection equipment, avoid picking up discarded needles with bare hands, and use protective barriers during activities with a risk of blood contact. If you work in law enforcement, sanitation, or any field where encountering discarded sharps is possible, puncture-resistant gloves and sharps containers are basic equipment worth having on hand.